<DOC>
	<DOCNO>NCT00297973</DOCNO>
	<brief_summary>Compare reduction Framingham 's predict 10-year risk coronary event ( 6 ) patient hypertension least three cardiovascular risk factor ( include diabetic patient ) see private practice randomize either Caduet usual care .</brief_summary>
	<brief_title>Cardiovascular Risk Assessment Patients Treated With Caduet</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1.Male female , 18 year age , 2.Patient hypertension least three CV risk factor , 3.Hypertension , treat , currently recommend goal ( 140/90 mmHg patient , 130/80 mmHg patient diabetes nephropathy ) . In case treat hypertension , patient current treatment least 4 week randomisation , 1 . Patient history coronary heart disease , 2.Patients history familial hypercholesterolemia , 3.Patient malignant HTN , 4.Nonessential hypertension , 5.Known hypersensitivity dihydropyridines , 6.Patients already receive dihydropyridine , 7.Known hypersensitivity HMGCoAreductase inhibitor , 8.Patients currently receive receive HMGCoAreductase within 3 month prior selection , 9.Patients currently receive receive fibric acid , resin , ezetimibe , nicotinic acid drug know affect lipid level , within 6 week prior selection ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>